Literature DB >> 2433662

Choroidal neovascularization.

W R Green, D J Wilson.   

Abstract

Choroidal neovascularization is now considered to be a most important feature in the pathogenesis and treatment of a number of chorioretinal disorders. Since the recognition of its importance, choroidal neovascularization has been described in clinical and pathologic studies of a variety of different ophthalmologic conditions. We have summarized the diseases in which choroidal neovascularization occurs and have reviewed studies on the natural history, clinical findings, and therapy of choroidal neovascularization that provide the basis for the current management of this condition.

Entities:  

Mesh:

Year:  1986        PMID: 2433662     DOI: 10.1016/s0161-6420(86)33609-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  36 in total

1.  Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor.

Authors:  Atsunobu Takeda; Yasuaki Hata; Satomi Shiose; Yukio Sassa; Masae Honda; Kimihiko Fujisawa; Taiji Sakamoto; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-23       Impact factor: 3.117

2.  Choroidal vascular repair: scanning and transmission electron microscopy.

Authors:  A Pollack; G E Korte
Journal:  Experientia       Date:  1992-03-15

3.  Choroidal neovascularisation associated with meningioma.

Authors:  M S Lee; S Lessell
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

4.  Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration.

Authors:  Quan Dong Nguyen; Syed Mahmood Shah; Gulnar Hafiz; Diana V Do; Julia A Haller; Roberto Pili; Ingrid E Zimmer-Galler; Kashif Janjua; R C Andrew Symons; Peter A Campochiaro
Journal:  Am J Ophthalmol       Date:  2007-12-11       Impact factor: 5.258

Review 5.  Retinal pigment epithelial cell proliferation.

Authors:  Jeffrey Stern; Sally Temple
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-02

6.  Epidemiology, treatment pattern and health care utilization of myopic choroidal neovascularization: a population based study.

Authors:  Ming-Chin Yang; Yen-Po Chen; Elise Chia-Hui Tan; Claudia Leteneux; Erin Chang; Carol Hy Chu; Chi-Chun Lai
Journal:  Jpn J Ophthalmol       Date:  2017-01-06       Impact factor: 2.447

Review 7.  Animal models of choroidal and retinal neovascularization.

Authors:  Hans E Grossniklaus; Shin J Kang; Lennart Berglin
Journal:  Prog Retin Eye Res       Date:  2010-05-19       Impact factor: 21.198

8.  Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization.

Authors:  Katsuji Kiuchi; Masato Matsuoka; Jenny C Wu; Raquel Lima e Silva; Muralitharan Kengatharan; Mary Verghese; Shinji Ueno; Katsutoshi Yokoi; Naw Htee Khu; John P Cooke; Peter A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

9.  Choroidal neovascular membrane following clear lens extraction.

Authors:  Banu Turgut Oztürk; Hürkan Kerimoğlu; Umit Kamış; Saban Gönül; Süleyman Okudan
Journal:  Clin Ophthalmol       Date:  2007-12

Review 10.  Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.

Authors:  Claudio Campa; Ciro Costagliola; Carlo Incorvaia; Carl Sheridan; Francesco Semeraro; Katia De Nadai; Adolfo Sebastiani; Francesco Parmeggiani
Journal:  Mediators Inflamm       Date:  2010-08-25       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.